Literature DB >> 30156997

Surgical Instrument Reprocessing in Resource-Constrained Countries: A Scoping Review of Existing Methods, Policies, and Barriers.

Jared A Forrester1,2, Brittany Lynn Powell3, Joseph D Forrester1, Christina Fast4, Thomas G Weiser1,2,5.   

Abstract

BACKGROUND: Surgical infections are a major cause of morbidity and mortality in low- and middle-income countries (LMICs). Inadequately reprocessed surgical instruments can be a vector for pathogens. Little has been published on the current state of surgical instrument reprocessing in LMICs.
METHODS: We performed a scoping review of English-language articles in PubMed, Web of Science, and Google Scholar databases describing current methods, policies, and barriers to surgical instrument reprocessing in LMICs. We conducted qualitative analysis of all studies to categorize existing practices and barriers to successful surgical instrument reprocessing. Barriers were non-exclusively categorized by theme: training/education, resource availability, environment, and policies/procedures. Studies associating surgical infections with existing practices were separately evaluated to assess this relationship.
RESULTS: Nine hundred seventy-two abstracts were identified. Forty studies met criteria for qualitative analysis and three studies associated patient outcomes with surgical instrument reprocessing. Most studies (n = 28, 70%) discussed institution-specific policies/procedures; half discussed shortcomings in staff training. Sterilization (n = 38, 95%), verification of sterilization (n = 19, 48%), and instrument cleaning and decontamination (n = 16, 40%) were the most common instrument reprocessing practices examined. Poor resource availability and the lack of effective education/training and appropriate policies/procedures were cited as the common barriers. Of the case series investigating surgical instrument reprocessing with patient outcomes, improperly cleaned and sterilized neurosurgical instruments and contaminated rinse water were linked to Pseudomonas aeruginosa ventriculitis and Mycobacterium port site infections, respectively.
CONCLUSIONS: Large gaps exist between instrument reprocessing practices in LMICs and recommended policies/procedures. Identified areas for improvement include instrument cleaning and decontamination, sterilization aspects of instrument reprocessing, and verification of sterilization. Education and training of staff responsible for reprocessing instruments and realistic, defined policies and procedures are critical, and lend themselves to improvement interventions.

Entities:  

Keywords:  education; global surgery; infection; patient safety; training

Mesh:

Year:  2018        PMID: 30156997     DOI: 10.1089/sur.2018.078

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  4 in total

1.  Sterile processing in low- and middle-income countries: an integrative review.

Authors:  Alexander Cuncannon; Aliyah Dosani; Olive Fast
Journal:  J Infect Prev       Date:  2020-08-29

2.  Early Functional Outcome of Hemiarthroplasty in the Elderly with Neck of Femur Fracture: A Single Centre's Experience.

Authors:  Muhammad Musa Chiroma; Mustapha Usman Ibrahim; Muhammed Nuhu Salihu; Francis Olusoji Awonusi; Abdul Rahman Alhaji Mamuda; Muhammad Kabir Abubakar; Kabir Musa Adamu; Shamsuddeen Muhammad; Bashir Bello
Journal:  J West Afr Coll Surg       Date:  2022-08-27

Review 3.  Challenges regarding the control of environmental sources of contamination in healthcare settings in low-and middle-income countries - a narrative review.

Authors:  Folasade T Ogunsola; Shaheen Mehtar
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-09       Impact factor: 4.887

4.  Assessment of laparoscopic instrument reprocessing in rural India: a mixed methods study.

Authors:  Daniel Robertson; Jesudian Gnanaraj; Linda Wauben; Jan Huijs; Vasanth Mark Samuel; Jenny Dankelman; Tim Horeman-Franse
Journal:  Antimicrob Resist Infect Control       Date:  2021-07-23       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.